ClinConnect ClinConnect Logo
Search / Trial NCT06921434

the Effect of Monk Fruit and Splenda on Salivary Ph and Streptococcus Mutans Count in Vivo Study

Launched by AL-MUSTANSIRIYAH UNIVERSITY · Apr 8, 2025

Trial Information

Current as of June 18, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how two sweeteners, Monk Fruit and Splenda, affect saliva's acidity and the amount of a specific bacteria called Streptococcus mutans, which is linked to tooth decay. Participants will use a mouth rinse made with these sweeteners and then have their saliva tested to see how the rinse changes the saliva’s pH (which indicates acidity) and the count of the bacteria. The study will measure these changes at different times after using the rinse.

To join this study, participants should be healthy individuals aged 20 to 24, with no current tooth decay or oral diseases. They should not have received any recent dental treatments or be taking medications that affect saliva flow. Those who have active cavities or painful oral conditions won’t be eligible. Participants can expect to provide saliva samples before and after using the mouth rinse, and the study is designed to help understand how these sweeteners might influence oral health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • participants aged (20-24) years.
  • No active carious lesions or oral diseases.
  • Generally healthy individuals without systemic illnesses.
  • No prior use of preventive dental treatments
  • Exclusion Criteria:
  • Participants currently undergoing dental treatment.
  • Those taking medications that alter saliva flow.
  • Presence of painful oral conditions or systemic diseases. Participants have active caries

About Al Mustansiriyah University

Al-Mustansiriyah University is a prominent academic institution located in Baghdad, Iraq, dedicated to advancing education, research, and healthcare. As a clinical trial sponsor, the university leverages its expertise in medical and scientific research to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a commitment to ethical standards and rigorous scientific methodologies, Al-Mustansiriyah University collaborates with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and reliability of its clinical trials, ultimately striving to enhance public health and advance medical practices within the region and beyond.

Locations

Baghdad, , Iraq

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported